Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

N. Nathalie Bouwer, T. G. Steenbruggen, H. N. Rier, J. J. E. M. Kitzen, K. J. Beelen, A. J. Ten Tije, P. C. De Jong, J. C. Drooger, C. Holterhues, J. Van Rosmalen, M. J. M. Kofflard, E. Boersma, G. S. Sonke, M-D Levin, A. Jager

Research output: Contribution to journalMeeting AbstractAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Article numberP1170
Pages (from-to)289-290
Number of pages2
JournalEuropean Journal of Heart Failure
Volume21
Issue numberSuppl 1
DOIs
Publication statusPublished - 26 May 2019

Bibliographical note

© 2019 The Authors

Cite this